Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 11/20 | 0.52 |
| ▸ | CES2 | O00748 | 6/20 | 0.52 |
| ▸ | FAAH | O00519 | 12/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8015947 | 1.00 | CES1 (0.52) | CES1CES2FAAHMEN1KMT2A | |
| SCHEMBL8013027 | 1.00 | CES1 (0.52) | CES1CES2FAAHMEN1KMT2A | |
| SCHEMBL3437239 | 1.00 | CES1 (0.52) | CES1CES2FAAHMEN1KMT2A | |
| SCHEMBL8016101 | 0.91 | FAAH (0.56) | CES1FAAHKMT2ACYP1A2HSD17B10 | |
| SCHEMBL3777162 | 0.89 | FAAH (0.59) | CES1CES2FAAHMEN1KMT2A | |
| SCHEMBL3778978 | 0.89 | FAAH (0.59) | CES1CES2FAAHMEN1KMT2A | |
| SCHEMBL3787603 | 0.89 | FAAH (0.59) | CES1CES2FAAHMEN1KMT2A | |
| SCHEMBL3777756 | 0.89 | FAAH (0.59) | CES1CES2FAAHMEN1KMT2A | |
| SCHEMBL9435633 | 0.89 | FAAH (0.59) | CES1CES2FAAHMEN1KMT2A | |
| SCHEMBL4812989 | 0.86 | CES1 (0.52) | CES1CES2FAAHMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6090800-A | REACTION PRODUCT CONTAINING DEXAMETHASONE | IMARX PHARMACEUTICAL CORP. (US) | 2000-07-18 | — | — | US | claimed |
| WO-2024133635-A1 | COMPOSITION | BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| EP-0523189-B1 | CATIONIC LIPIDS FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | VICAL INC (US) | 1999-06-16 | — | — | EP | disclosed |